MongoDB stock rises nearly 4% as investors cheer strong Q2 results and cloud growth

Traders Union
All News
Stocks
Mongodb rises 3.83% today on results

Highlights

MongoDB revenue grew 30% year over year to $771.8 million, with Atlas revenue up 29% to $565.9 million.
Remaining performance obligations climbed 91% to $1.52 billion, and the company reduced its outstanding shares by 0.7%.
Shares of MongoDB trade below short- and medium-term moving averages with oversold oscillator readings and a projected 5-day range of $359.8 to $385.58.

Future contract strength as Atlas drives broad revenue expansion

MongoDB reported fiscal second-quarter revenue of $771.8 million, up 30% year over year, with its cloud product Atlas increasing by approximately 29% to $565.9 million. Remaining performance obligations reached $1.52 billion, up 91% year over year, reflecting strong future contracted revenue. Enterprise Advanced and other revenues climbed around 36%, and the company’s participation in Citi’s 2026 Global TMT Conference accompanied a 0.7% reduction in outstanding common shares through its recent repurchase program.

Anton Kharitonov, expert at Traders Union, sees the recent price advance in MongoDB as fragile. Despite solid revenue growth and a boost in future contracts, he finds technical signals overwhelmingly negative. MDB is trading below short- and medium-term averages, with oversold readings failing to attract buyers. Persistent seller dominance, as shown by low CCI and negative BBP, casts doubt on a sustainable rebound. "I remain cautious, as current momentum and technicals strongly favor downside risk over recovery," Kharitonov warns.

Viktoras Karapetjanc, expert at Traders Union, believes MongoDB's impressive revenue acceleration underscores robust business fundamentals. He notes the 91% rise in future contracted revenue and continued growth in Atlas as indicators of strong institutional and enterprise adoption. Participation at major industry events and share buybacks support a positive market sentiment. Karapetjanc sees the bullish structure intact despite recent volatility. "With revenue momentum and pipeline strength, further growth is expected as the market offers multiple setups for upside participation," he states.

Parshwa Turakhiya, analyst, highlights mixed sentiment as MDB hovers near session highs despite oversold technicals. He interprets the current range between $359.8 and $385.58 as fertile ground for short-term traders. Daily volatility offers opportunities for both momentum plays and quick reversals. "I see scope for agile traders to capitalize on price swings while the broader trend remains unresolved," Turakhiya remarks.

Short-term selling persists as oversold signals meet mixed momentum

MDB is trading below its 20-day ($418.3) and 50-day ($374.67) moving averages, but remains above the 200-day ($342.64), indicating continued short- and medium-term selling pressure despite a constructive long-term bias. Resistance stands at $374.67 and support at $359.8. Daily momentum appears mixed, with a neutral MACD and an ADX reading that suggests no clear trend. The RSI at 40.53, Stochastic RSI at 2.8, CCI at -141.77, and BBP at -29.22 all highlight oversold conditions. Continued negative BBP and low CCI reinforce ongoing seller dominance for intraday momentum. Despite these signals, MDB is trading near session highs with intraday volatility of 5.85%.

Earlier, analysts noted that MongoDB remained in a broadly bullish technical structure despite short-term downside risk following softer momentum signals. The current setup reinforces that view, with the stock exhibiting continued selling pressure over short- and medium-term periods, making the $359.8 support level critical for traders monitoring potential further downside.

Source of Data: MDB Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.